Read More The 5 year long AREDS 2 trial has finished. Initial results have. been published with some interesting findings. AREDS 2 reports results Read More Find out more about one of the leading causes of permanent vision loss in those over 60 in the western world. Macular degeneration Read More What we eat has an impact on general health and this applies to ocular health as well. The role of nutrition and diet Read More There are a lot of nutritional supplements on the market but choosing the right one can be difficult, let us help. Choosing the right supplement

The long-anticipated Age-Related Eye Disease Study part 2 (AREDS2) results were announced at the Association for Research in Vision and Ophthalmology (ARVO) in Seattle on May 5th 2013. This complex study began in 2006 and included 4203 participants and 82 clinics through the United States. It was designed to find out the best combination of vitamins, minerals and carotenoids to delay the progression of Age-related Macular Degeneration (AMD), currently a leading cause of sight loss in the developed world.

“Addition of lutein & zeaxanthin, DHA & EPA, or both to the AREDS formulation did not further reduce risk of progression to advanced AMD. However, because of the potential increased incidence of lung cancer in former smokers, lutein & zeaxanthin could be an appropriate substitute for beta-carotene in the AREDS formulation.”

The long-anticipated Age-Related Eye Disease Study part 2 (AREDS2) results were announced at the Association for Research in Vision and Ophthalmology (ARVO) in Seattle on May 5th 2013. This complex study began in 2006 and included 4203 participants and 82 clinics through the United States. It was designed to find out the best combination of vitamins, minerals and carotenoids to delay the progression of Age-related Macular Degeneration (AMD), currently a leading cause of sight loss in the developed world.